AstraZeneca FD may leave
Jon Symonds, the finance director of AstraZeneca, is believed to be pondering his future after being overlooked for the drug company's top job
The respected finance director of AstraZeneca, Jon Symonds, may decide to
leave the FTSE100 drug-maker after he was edged out by David Brennan in the race
to replace AstraZeneca’s CEO Sir Tom McKillop.
Symonds, who has steered the company through a difficult period when its
shares plummeted due to problems with its drug development pipeline, said he
would ‘work it through’ with Brennan before making a decision about his future
at the group.
‘The best man won – that’s who the board picked,’ Symonds told The
Times.
If Symonds does leave AstraZeneca, the 100 Group, an association of FTSE100,
will be forced to recruit a new head, as Symonds currently chairs the
influential group.